Pharmaceuticals
Eli Lilly and Novo Nordisk Strike Weight-Loss Drug Deal with Trump Administration
Landmark agreement cuts drug prices, expands Medicare access, and grants tariff relief to leading obesity drugmakers Eli Lilly & Co....
Pfizer, Novo Nordisk Eye Metsera; Sarepta Sinks, Hertz Surges
Tuesday’s trading session saw major pharmaceutical deals, biotech setbacks, and a surprise comeback in the car rental sector. On Tuesday’s...
Kimberly-Clark and Kenvue Unite to Form Consumer Health Giant
Kimberly-Clark, the maker of household staples like Kleenex and Huggies, has announced plans to acquire Tylenol producer Kenvue in a...
Replimune Reports Promising New Data for Acral Melanoma Treatment at ESMO 2025
RP1 combined with nivolumab shows meaningful tumor response in rare and aggressive skin cancer Replimune Group (REPL), a clinical-stage biotechnology...
Praxis Announces Breakthrough Phase 3 Results for Ulixacaltamide in Essential Tremor Treatment
Positive data from Essential3 program marks major step toward first targeted therapy for millions living with essential tremor Praxis Precision...
Wall Street’s Biggest Analyst Calls Today: Upgrades Favor Tech, Downgrades Hit Industrials and Healthcare
Semiconductor optimism drives bullish calls on AMD and Monolithic Power while managed care stocks come under pressure Wall Street analysts...
Kenvue Rebounds After Tylenol Autism Claims Spark Market Jitters
Analysts cite lack of new scientific evidence as shares recover from record low Kenvue (KVUE) shares rose 6% on Tuesday,...
NeuroNOS Earns FDA Orphan Drug Designation for Glioblastoma Therapy
BA-101 aims to address urgent unmet needs in one of the deadliest brain cancers NeuroNOS, a subsidiary of Beyond Air...
Viking Therapeutics Shares Plunge After High Dropout Rate in Weight-Loss Pill Trial
Strong weight reduction overshadowed by concerns over side effects Viking Therapeutics (VKTX) shares plummeted nearly 45% on Tuesday after the...
Eli Lilly Strikes $1.3 Billion Deal with Superluminal Medicines to Advance AI-Driven Obesity Drug Development
Partnership leverages artificial intelligence to accelerate discovery of next-generation treatments for obesity and cardiometabolic diseases Eli Lilly (LLY) has entered...
